In the Taiwanese cohort, EHD3 hypermethylation was detected in 73.1% (19/26) of patients with CRC and 18.8% (3/16) of patients with esophageal cancer compared with matched normal tissues (Figure 2A and Figure S2). The gene discussed is EHD3; the disease is colorectal carcinoma.